A new study provides further evidence of the benefit of adjuvant radiation in men who have undergone radical prostatectomy and who have stage T3 disease. Medscape Medical News
Using a combination of cytotoxic chemotherapies vs sequential single agents in metastatic breast cancer is controversial. The ESO-MBC Task Force provides guidelines and recommendations. Journal of the National Cancer Institute
Bevacizumab-taxane combinations may provide an alternative to chemotherapy doublet regimens in first-line mBC, but is the toxicity profile tolerable? Annals of Oncology
The choice of surrogate and true end points is critical to reporting cancer data. What issues are involved in using progression-free survival as an endpoint in breast cancer and colorectal cancer? Annals of Oncology
